Cargando…
Management of Parathyroid Disease during the COVID-19 Pandemic
The coronavirus disease, COVID-19, has caused widespread and sustained disruption to healthcare, not only in the delivery of emergency care, but knock-on consequences have resulted in major delays to the delivery of elective care, including surgery. COVID-19 has accelerated novel pathways for delive...
Autores principales: | Aojula, Nivaran, Ready, Andrew, Gittoes, Neil, Hassan-Smith, Zaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956309/ https://www.ncbi.nlm.nih.gov/pubmed/33652905 http://dx.doi.org/10.3390/jcm10050920 |
Ejemplares similares
-
Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
por: Aojula, Nivaran, et al.
Publicado: (2021) -
Digitalising medical education: virtual ward rounds during COVID-19 and beyond
por: Hagana, Arwa, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis
por: Gittoes, Neil J, et al.
Publicado: (2020) -
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)
por: Bollerslev, Jens, et al.
Publicado: (2021) -
Exploring the barriers and facilitators of psychological safety in primary care teams: a qualitative study
por: Remtulla, Ridhaa, et al.
Publicado: (2021)